$588.23 0.6%
Price vs. AI Score (Last 150 days)
Data gathered: December 7

Data Bits

Data Bits Value / Change Benchmark
Job Posts 730 0.4%
Sentiment 82 -4.7%
Webpage traffic 924,000 -6.2%
Employee Rating 81 0%
Google Adspend $3,919 -6.4%
Google Trends -100%
Linkedin Employees 41,333 N/A
Patents 436 0%
4chan Mentions 0%
Facebook Engagement 355 63.6%
Facebook followers 242,252 0.2%
Stocktwits Mentions 46 -37.8%
Stocktwits Subscribers 14,711 0%
Twitter Followers 141,856 0%
Instagram Followers 31,087 0%
News Mentions 2 0%
Reddit Mentions 2 -33.3%
ESG 69 0%
Business outlook 84 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Eli Lilly and Company

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

Eli Lilly and Company
Price $588.23
Target Price Sign up
Market Cap $558B
Dividend Yield 0.0077
Industry Drug Manufacturers

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '239.5B3.55B5.95B-57M6.4B
Q2 '238.31B3.62B4.69B1.76B2.32B
Q1 '236.96B3.26B3.7B1.34B1.7B
Q4 '227.3B3.72B3.59B1.94B2.39B
Q3 '226.94B3.31B3.63B1.45B2.4B

Insider Transactions

Zakrowski Donald A filed to sell 4,708 shares at $571.1.
November 6 '23
LILLY ENDOWMENT INC filed to sell 99,768,810 shares at $607.7.
October 12 '23
Weems Alonzo filed to sell 7,760 shares at $591.
September 13 '23
LILLY ENDOWMENT INC filed to sell 99,983,810 shares at $575.4.
September 8 '23
LILLY ENDOWMENT INC filed to sell 100,193,810 shares at $557.2.
September 1 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.